ALKBH5 and ovarian carcinoma: The small molecules or drugs targeting ALKBH5 or IGF2BP2 were investigated using GDSC and CTRP database, which might help demonstrate the potential drugs that target ALKBH5 or IGF2BP2 in ovarian cancer (Fig. 5G-H).